{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:38:09Z","timestamp":1770824289076,"version":"3.50.1"},"reference-count":23,"publisher":"The Japan Society of Coloproctology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Anus Rectum Colon"],"published-print":{"date-parts":[[2021,10,28]]},"DOI":"10.23922\/jarc.2020-094","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T22:09:11Z","timestamp":1635372551000},"page":"340-345","source":"Crossref","is-referenced-by-count":1,"title":["Risk for Colorectal Cancer in Patients with Serially Positive Fecal Immunochemistry Test in an Annual Screening Program"],"prefix":"10.23922","volume":"5","author":[{"given":"Takuji","family":"Kawamura","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Kyoto Second Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kana","family":"Amamiya","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Kyoto Second Red Cross Hospital"},{"name":"Department of Health Care, Kyoto Second Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naonori","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Kyoto Second Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naokuni","family":"Sakiyama","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Kyoto Second Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Kyoto Second Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kasumi","family":"Sanada","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Kyoto Second Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai","family":"Kamaguchi","sequence":"additional","affiliation":[{"name":"Department of Health Care, Kyoto Second Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Nishioji","sequence":"additional","affiliation":[{"name":"Department of Health Care, Kyoto Second Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyohito","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Kyoto Second Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Uno","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Kyoto Second Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenjiro","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Kyoto Second Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10009","reference":[{"key":"1","unstructured":"1. National guidelines for population based cancer screening programs. Ministry of Health, Labour and Welfare. https:\/\/wwwmhlwgojp\/bunya\/kenkou\/dl\/gan_kenshin01pdf Accessed 12 Sep 2020 (in Japanese)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Saito H, Kudo SE, Takahashi N, et al. Efficacy of screening using annual fecal immunochemical test alone versus combined with one-time colonoscopy in reducing colorectal cancer mortality: the Akita Japan population-based colonoscopy screening trial (Akita pop-colon trial). Int J Colorectal Dis. 2020 May; 35 (5): 933-9.","DOI":"10.1007\/s00384-020-03518-w"},{"key":"3","unstructured":"3. Koike K. Evidence-based clinical practice guidelines for colonic polyp 2020. 2nd ed. Tokyo: Nankodo; 2020 (in Japanese)."},{"key":"4","unstructured":"4. Mizuguchi M, Miyagawa K, Fujiya M, et al. Heisei 28-nendo Shokaki Gan Kenshin Zenkoku Syukei (National Statistics for Gastrointestinal Cancer Screening in 2016). Journal of Gastrointestinal Cancer Screening. 2019 Nov; 57 (6): 1173-217 (in Japanese)."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Maida M, Sferrazza S, Savarino E, et al. Impact of the COVID-19 pandemic on Gastroenterology Divisions in Italy: a national survey. Dig Liver Dis. 2020 Aug; 52 (8): 808-15.","DOI":"10.1016\/j.dld.2020.05.017"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kawamura T, Inoue T, Shinomiya R, et al. Significance of fecal hemoglobin concentration for predicting risk of colorectal cancer after colonoscopy. JGH Open. 2020 Oct; 4 (5): 898-902.","DOI":"10.1002\/jgh3.12346"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med. 1993 May 13; 328 (19): 1365-71.","DOI":"10.1056\/NEJM199305133281901"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996 Nov 30; 348 (9040): 1467-71.","DOI":"10.1016\/S0140-6736(96)03430-7"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996 Nov 30; 348 (9040): 1472-7.","DOI":"10.1016\/S0140-6736(96)03386-7"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000 Nov 30; 343 (22): 1603-7.","DOI":"10.1056\/NEJM200011303432203"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Faivre J, Dancourt V, Lejeune C, et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology. 2004 Jun; 126 (7): 1674-80.","DOI":"10.1053\/j.gastro.2004.02.018"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Chiu HM, Chen SL, Yen AM, et al. Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the one million Taiwanese screening program. Cancer. 2015 Sep 15; 121 (18): 3221-9.","DOI":"10.1002\/cncr.29462"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Meester RG, Zauber AG, Doubeni CA, et al. Consequences of increasing time to colonoscopy examination after positive result from fecal colorectal cancer screening test. Clin Gastroenterol Hepatol. 2016 Oct; 14 (10): 1445-51.e8.","DOI":"10.1016\/j.cgh.2016.05.017"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Corley DA, Jensen CD, Quinn VP, et al. Association between time to colonoscopy after a positive fecal test result and risk of colorectal cancer and cancer stage at diagnosis. JAMA. 2017 Apr 25; 317 (16): 1631-41.","DOI":"10.1001\/jama.2017.3634"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Lee YC, Fann JC, Chiang TH, et al. Time to colonoscopy and risk of colorectal cancer in patients with positive results from fecal immunochemical tests. Clin Gastroenterol Hepatol. 2019 Jun; 17 (7): 1332-40.e3.","DOI":"10.1016\/j.cgh.2018.10.041"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Zorzi M, Hassan C, Capodaglio G, et al. Colonoscopy later than 270 days in a fecal immunochemical test-based population screening program is associated with higher prevalence of colorectal cancer. Endoscopy. 2020 Oct; 52 (10): 871-6.","DOI":"10.1055\/a-1159-0644"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Marcello M. Screening of gastrointestinal cancers during COVID-19: a new emergency. Lancet Oncol. 2020 Jul; 21 (7): e338.","DOI":"10.1016\/S1470-2045(20)30341-7"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. de Jonge L, Worthington J, van Wifferen F, et al. Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study. Lancet Gastroenterol Hepatol. 2021 Apr; 6 (4): 304-14.","DOI":"10.1016\/S2468-1253(21)00003-0"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Sung JJY, Wong MCS, Lam TYT, et al. A modified colorectal screening score for prediction of advanced neoplasia: a prospective study of 5744 subjects. J Gastroenterol Hepatol. 2018 Jan; 33 (1): 187-94.","DOI":"10.1111\/jgh.13835"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Sekiguchi M, Kakugawa Y, Matsumoto M, et al. A scoring model for predicting advanced colorectal neoplasia in a screened population of asymptomatic Japanese individuals. J Gastroenterol. 2018 Oct; 53 (10): 1109-19.","DOI":"10.1007\/s00535-018-1433-7"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Peng L, Weigl K, Boakye D, et al. Risk scores for predicting advanced colorectal neoplasia in the average-risk population: a systematic review and meta-analysis. Am J Gastroenterol. 2018 Dec; 113 (12): 1788-800.","DOI":"10.1038\/s41395-018-0209-2"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Yeoh KG, Ho KY, Chiu HM, et al. The Asia-Pacific colorectal screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut. 2011 Sep; 60 (9): 1236-41.","DOI":"10.1136\/gut.2010.221168"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Lieberman DA, Prindiville S, Weiss DG, et al. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA. 2003 Dec 10; 290 (22): 2959-67.","DOI":"10.1001\/jama.290.22.2959"}],"container-title":["Journal of the Anus, Rectum and Colon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jarc\/5\/4\/5_2020-094\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T05:17:11Z","timestamp":1715145431000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jarc\/5\/4\/5_2020-094\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,28]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.23922\/jarc.2020-094","relation":{},"ISSN":["2432-3853"],"issn-type":[{"value":"2432-3853","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,28]]},"article-number":"2020-094"}}